The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

27 articles for HQ Li


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED binding.EBI
Abbvie
Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents.EBI
Soochow University
Combination of 4-anilinoquinazoline and rhodanine as novel epidermal growth factor receptor tyrosine kinase inhibitors.EBI
Soochow University
Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 Diabetes.EBI
Pfizer
Design, synthesis and molecular docking ofa,ß-unsaturated cyclohexanone analogous of curcumin as potent EGFR inhibitors with antiproliferative activity.EBI
Soochow University
Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents.EBI
Nanjing University
Design and synthesis of 4,6-substituted-(diaphenylamino)quinazolines as potent EGFR inhibitors with antitumor activity.EBI
Soochow University
Discovery of vinylogous carbamates as a novel class ofß-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.EBI
Soochow University
Design, synthesis and biological evaluation of quinoline amide derivatives as novel VEGFR-2 inhibitors.EBI
Nanjing University
Synthesis, biological evaluation and molecular docking studies of amide-coupled benzoic nitrogen mustard derivatives as potential antitumor agents.EBI
Nanjing University
Synthesis and structure-activity relationships of N-benzyl-N-(X-2-hydroxybenzyl)-N'-phenylureas and thioureas as antitumor agents.EBI
Nanjing University
Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors.EBI
Nanjing University
Efficacious 11beta-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse model.EBI
Wyeth Research
Piperazine sulfonamides as potent, selective, and orally available 11beta-hydroxysteroid dehydrogenase type 1 inhibitors with efficacy in the rat cortisone-induced hyperinsulinemia model.EBI
Wyeth Research
Identification of a novel class of selective Tpl2 kinase inhibitors: 4-Alkylamino-[1,7]naphthyridine-3-carbonitriles.EBI
Wyeth Research
Inhibition of Tpl2 kinase and TNFalpha production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis.EBI
Wyeth Research
Inhibition of Tpl2 kinase and TNF-alpha production with 1,7-naphthyridine-3-carbonitriles: synthesis and structure-activity relationships.EBI
Wyeth Research
Discovery of novel 4-anilinoquinazoline derivatives as potent inhibitors of epidermal growth factor receptor with antitumor activity.EBI
Soochow University
Structure-based design of rhodanine-based acylsulfonamide derivatives as antagonists of the anti-apoptotic Bcl-2 protein.EBI
Soochow University
Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors.EBI
Nanjing University
Amines and oximes derived from deoxybenzoins as Helicobacter pylori urease inhibitors.EBI
Nanjing University
Polyphenols based on isoflavones as inhibitors of Helicobacter pylori urease.EBI
Nanjing University
Alkylene derivativesBDB
Shionogi
Tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and/or LSD2BDB
Sapienza University of Rome
Lipoamide channel-binding sulfonamides selectively inhibit mycobacterial lipoamide dehydrogenase.BDB
Weill Cornell Medical College
Imidazo[1,2-a]pyridines and imidazo[1,2-b]pyridazines as mark inhibitorsBDB
Merck Sharp & Dohme
The reversed binding of beta-phenethylamine inhibitors of DPP-IV: X-ray structures and properties of novel fragment and elaborated inhibitors.BDB
Santhera Pharmaceuticals